News & Filings
JAGSNPHARM \u2014 Recent Activity
2 items in the last 14 days
Jagsonpal Pharmaceuticals Ltd (BOM:507789) Q3 2026 Earnings Call Highlights: Strategic Growth ...
Despite a 6% revenue growth and strong cash reserves, Jagsonpal Pharmaceuticals Ltd faces industry headwinds and strategic realignments impacting short-term performance.
Click to open →
Jagsonpal Pharmaceuticals Ltd (BOM:507789) Q2 2026 Earnings Call Highlights: Navigating ...
Despite market challenges, Jagsonpal Pharmaceuticals Ltd (BOM:507789) reports robust sales growth and strategic leadership appointments to drive future success.
Click to open →
Get alerts for important filings
Add JAGSNPHARM to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.